We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+4.16%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$164B
AUM Growth
+$8.29B
Cap. Flow
+$3.5B
Cap. Flow %
2.13%
Top 10 Hldgs %
14.82%
Holding
3,341
New
147
Increased
2,302
Reduced
628
Closed
129

Top Buys

Rank Stock Value
1
DOW icon
Dow Inc
DOW
+$173M
2
AMCR icon
Amcor
AMCR
+$138M
3
MSFT icon
Microsoft
MSFT
+$99.3M
4
AMZN icon
Amazon
AMZN
+$97.5M
5
INTC icon
Intel
INTC
+$96.8M

Sector Composition

Rank Sector Weight
1 Technology 16.86%
2 Financials 14.49%
3 Healthcare 12.78%
4 Industrials 10.5%
5 Consumer Discretionary 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCB icon
3051
Coastal Financial
CCB
$744M
$258K ﹤0.01%
16,651
+1,578
+10% +$25.7K
LCTX icon
3052
Lineage Cell Therapeutics
LCTX
$286M
$258K ﹤0.01%
233,687
STRO icon
3053
Sutro Biopharma
STRO
$423M
$258K ﹤0.01%
2,259
+948
+72% +$104K
UBP
3054
DELISTED
Urstadt Biddle Properties Inc.
UBP
$255K ﹤0.01%
14,868
+335
+2% +$5.77K
ADMA icon
3055
ADMA Biologics
ADMA
$2.19B
$253K ﹤0.01%
65,180
+21,480
+49% +$94.8K
BLCM
3056
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$253K ﹤0.01%
14,827
-8,468
-36% -$229K
SBS icon
3057
Sabesp
SBS
$18.3B
$252K ﹤0.01%
+106,771
New +$233K
TESS
3058
DELISTED
Tessco Technologies Inc
TESS
$252K ﹤0.01%
+14,089
New +$258K
GEN
3059
DELISTED
Genesis Healthcare, Inc.
GEN
$251K ﹤0.01%
202,172
+68,619
+51% +$87.4K
FGBI icon
3060
First Guaranty Bancshares
FGBI
$139M
$246K ﹤0.01%
14,261
LQDA icon
3061
Liquidia Corp
LQDA
$8.1B
$246K ﹤0.01%
30,682
+13,502
+79% +$127K
GCBC icon
3062
Greene County Bancorp
GCBC
$583M
$237K ﹤0.01%
16,070
EYPT icon
3063
EyePoint Inc
EYPT
$1.13B
$236K ﹤0.01%
14,341
+12,881
+882% +$217K
USX
3064
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$236K ﹤0.01%
45,894
SBBP
3065
DELISTED
Strongbridge Biopharma plc.
SBBP
$236K ﹤0.01%
+75,231
New +$276K
VBIV
3066
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$235K ﹤0.01%
6,695
+5,819
+664% +$316K
EVER icon
3067
EverQuote
EVER
$900M
$230K ﹤0.01%
+17,637
New +$183K
DZSI
3068
DELISTED
DZS Inc. Common Stock
DZSI
$227K ﹤0.01%
17,422
+1,952
+13% +$23.2K
TPST icon
3069
Tempest Therapeutics
TPST
$16.6M
$226K ﹤0.01%
+100
New +$294K
TZOO icon
3070
Travelzoo
TZOO
$74.3M
$225K ﹤0.01%
14,548
-57,853
-80% -$974K
PARAA
3071
DELISTED
Paramount Global Class A
PARAA
$223K ﹤0.01%
4,440
INAP
3072
DELISTED
Internap Corporation
INAP
$223K ﹤0.01%
73,783
-45,940
-38% -$163K
SBOW
3073
DELISTED
SilverBow Resources, Inc.
SBOW
$221K ﹤0.01%
15,939
HBIO icon
3074
Harvard Bioscience
HBIO
$28.9M
$219K ﹤0.01%
10,942
+3,425
+46% +$100K
NATR icon
3075
Nature's Sunshine
NATR
$277M
$219K ﹤0.01%
23,543
+3,034
+15% +$28.4K

Similar funds

Charles Schwab's Q2 2019 Portfolio in Review

As of Q2 2019, Charles Schwab held 3,341 positions worth $164B, up 5.3% from $156B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Charles Schwab's Q2 2019 filing shows 147 new, 2,302 increased, 628 reduced and 129 closed positions. Its largest new stake was Dow Inc: 3,280,629 shares worth $162M. The largest sale was DuPont de Nemours, an estimated $126M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q2 2019 buy was Dow Inc: 3,280,629 shares worth $162M.
  • Charles Schwab added most to Microsoft in Q2 2019, an estimated $99.3M increase.
  • Charles Schwab's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $126M.
  • Charles Schwab fully exited China Mobile Limited in Q2 2019, selling an estimated $58.6M.
  • Charles Schwab's ten largest holdings make up 15% of its $164B portfolio in Q2 2019.
  • Charles Schwab opened 147 new positions and closed 129 in Q2 2019.
  • Charles Schwab's portfolio value rose 5.3% quarter-over-quarter to $164B.

Based on Charles Schwab's 13F filing for Q2 2019, filed 9 Aug 2019.